Literature DB >> 6517054

Abnormalities in the cell-division cycle in Roberts syndrome fibroblasts: a cellular basis for the phenotypic characteristics?

D J Tomkins, J E Sisken.   

Abstract

Roberts-SC phocomelia syndrome (RS) is a recessively inherited developmental disorder characterized by profound pre- and postnatal growth reduction, symmetrical limb reductions of varying severity, and craniofacial abnormalities. Many patients with RS exhibit a striking chromosomal abnormality involving the heterochromatic, C-banding regions of most chromosomes. Dermal fibroblast strains from three such patients were used to investigate in vitro cellular growth characteristics. Plating efficiency, colony-forming ability, and cell density at confluence in RS were compared with dermal fibroblast strains from pediatric patients without RS and fetal lung fibroblast strains. Time-lapse cinematography was used to study mitotic duration and cytokinesis in RS and various control fibroblast strains. Clearly, cell from affected individuals had deficiencies that led to a multitude of abnormalities at the cellular level. These included: abnormal mitosis and cytokinesis, reduced cell growth, atypical cell morphology, and altered chromosomal morphology at peri- and paracentromeric and nucleolar-organizing regions. These findings suggest that the basis for at least some of the phenotypic abnormalities characteristic of this trait may reside in the reduced growth rates of the cells during the course of development. This could account for the reduced pre- and postnatal growth rates as well as for the developmental abnormalities, since deficiencies of cells in developing anlagen could well lead to alterations in developmental patterns.

Entities:  

Mesh:

Year:  1984        PMID: 6517054      PMCID: PMC1684655     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  12 in total

1.  The SC phocomelia and the Roberts syndrome: nosologic aspects.

Authors:  J Herrmann; J M Opitz
Journal:  Eur J Pediatr       Date:  1977-06-01       Impact factor: 3.183

2.  Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures.

Authors:  D J Segal; E E McCoy
Journal:  J Cell Physiol       Date:  1974-02       Impact factor: 6.384

3.  Comparison of cell cycle time in normal and trisomic cells.

Authors:  G R Paton; M F Silver; A C Allison
Journal:  Humangenetik       Date:  1974

4.  Differential cell division in human X chromosome mosaics.

Authors:  P W Barlow
Journal:  Humangenetik       Date:  1972

5.  The Roberts syndrome.

Authors:  M V Freeman; D W Williams; R N Schimke; S A Temtamy; E Vachier; J German
Journal:  Clin Genet       Date:  1974-01       Impact factor: 4.438

6.  The prolongation of mitotic stages in SV40-transformed vs nontransformed human fibroblast cells.

Authors:  J E Sisken; S V Bonner; S D Grasch
Journal:  J Cell Physiol       Date:  1982-11       Impact factor: 6.384

7.  Two children with deletion of the long arm of chromosome 4 with breakpoint at band q33.

Authors:  D J Tomkins; A G Hunter; I A Uchida; M H Roberts
Journal:  Clin Genet       Date:  1982-12       Impact factor: 4.438

8.  Systematic growth studies, cocultivation, and cell hybridization studies of Werner syndrome cultured skin fibroblasts.

Authors:  D Salk; E Bryant; K Au; H Hoehn; G M Martin
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Roberts' syndrome. I. Cytological evidence for a disturbance in chromatid pairing.

Authors:  J German
Journal:  Clin Genet       Date:  1979-12       Impact factor: 4.438

10.  The SC phocomelia syndrome: report of two cases with cytogenetic abnormality.

Authors:  Q H Qazi; E G Kassner; A Masakawa; C Madahar; S J Choi
Journal:  Am J Med Genet       Date:  1979
View more
  12 in total

1.  Replication timing of homologous alpha-satellite DNA in Roberts syndrome.

Authors:  A C Barbosa; P A Otto; A M Vianna-Morgante
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

Review 2.  Roberts-SC phocomelia syndrome.

Authors:  A Maheshwari; P Kumar; S Dutta; A Narang
Journal:  Indian J Pediatr       Date:  2001-06       Impact factor: 1.967

Review 3.  Roles of the sister chromatid cohesion apparatus in gene expression, development, and human syndromes.

Authors:  Dale Dorsett
Journal:  Chromosoma       Date:  2006-07-04       Impact factor: 4.316

Review 4.  Dissecting the mechanisms of cell division.

Authors:  Joseph Y Ong; Jorge Z Torres
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

5.  Studies of mitotic and centromeric abnormalities in Roberts syndrome: implications for a defect in the mitotic mechanism.

Authors:  E W Jabs; C M Tuck-Muller; R Cusano; J B Rattner
Journal:  Chromosoma       Date:  1991-05       Impact factor: 4.316

6.  The expanding phenotypes of cohesinopathies: one ring to rule them all!

Authors:  Jessica Piché; Patrick Piet Van Vliet; Michel Pucéat; Gregor Andelfinger
Journal:  Cell Cycle       Date:  2019-09-13       Impact factor: 4.534

7.  Inactivating mutations in ESCO2 cause SC phocomelia and Roberts syndrome: no phenotype-genotype correlation.

Authors:  Birgitt Schüle; Angelica Oviedo; Kathreen Johnston; Shashidhar Pai; Uta Francke
Journal:  Am J Hum Genet       Date:  2005-10-31       Impact factor: 11.025

8.  Chromatid repulsion associated with Roberts/SC phocomelia syndrome is reduced in malignant cells and not expressed in interspecies somatic-cell hybrids.

Authors:  N E Krassikoff; J M Cowan; D M Parry; U Francke
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

9.  Gene clusters, molecular evolution and disease: a speculation.

Authors:  Leah I Elizondo; Paymaan Jafar-Nejad; J Marietta Clewing; Cornelius F Boerkoel
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

Review 10.  Cohesin Mutations in Cancer: Emerging Therapeutic Targets.

Authors:  Jisha Antony; Chue Vin Chin; Julia A Horsfield
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.